Archives
-
From Chromatin Mechanism to Translational Readouts
2026-10-08
The 2026 Magnaporthe oryzae study links MoCul4, MoKmt1, H3K9me3, heterochromatin integrity, and pathogenicity. This article interprets the findings for translational researchers and explains where reverse-transcription qPCR can support—without replacing—chromatin, protein, and phenotype-level evidence.
-
HyperScript™ IV RT SuperMix: Evidence Context
2026-10-08
HyperScript™ IV RT SuperMix for qPCR is a reverse-transcription and quantitative PCR reagent product whose supplied dossier establishes product identity but does not provide composition or performance benchmarks. The linked 2026 study shows that MoKmt1 and MoCul4 are associated with H3K9 trimethylation, development, and pathogenicity in Magnaporthe oryzae, but the study does not validate this product.
-
Plerixafor (AMD3100): CXCR4 Research Overview
2026-10-07
Plerixafor, also known as AMD3100, is a CXCR4 antagonist used to study CXCL12-dependent cell trafficking. This overview compares supplier-described pharmacology with a supplied in vivo study of platelet extravasation into tumors, emphasizing what the evidence supports, where findings remain preclinical, and why tumor growth, metastasis, hematopoietic stem cell mobilization, neutrophil trafficking, and WHIM syndrome treatment research should not be treated as interchangeable applications.
-
Polymyxin B: Evidence, Scope and Limitations
2026-10-07
This source-grounded overview answers five questions about Polymyxin B and Polymyxin B sulfate: how the antibiotic is understood to work, what evidence supports antimicrobial and immune-related claims, how to interpret resistance research, and where applicability and safety conclusions remain limited.
-
Oligo (dT) 25 Beads: Product Overview
2026-10-06
Oligo (dT) 25 Beads are superparamagnetic particles described by APExBIO for conceptual polyA tail mRNA capture from eukaryotic RNA samples. No matched peer-reviewed paper evidence was provided, so performance and downstream applicability remain unverified.
-
HyperScript III RT SuperMix: Evidence-Aware CRC qPCR
2026-10-06
HyperScript III RT SuperMix can support evidence-aware gene expression analysis by qPCR when colorectal cancer biomarker discoveries move from transcriptomic association toward analytical validation. This article examines how reverse-transcription fidelity, genomic DNA contamination removal, and study-design limitations shape interpretation of CLCA1, UGT2A3, and ZG16 findings.
-
Cyclopamine Through a Cross-Species Lens
2026-10-05
Cyclopamine is a Hedgehog signaling inhibitor best understood through both pathway biology and evidence boundaries. This article examines how honeybee Smo research broadens interpretation of cancer, developmental, and olfactory findings without overstating cross-species relevance.
-
Merbromin and SARS-CoV-2 3CLpro Inhibition
2026-10-05
The reference study used high-throughput biochemical screening and orthogonal mechanistic analyses to identify merbromin as a selective inhibitor of SARS-CoV-2 3CLpro. Its mixed-type kinetic profile and evidence for more than one binding site make the compound a useful lead for early protease-inhibitor research, while the findings remain limited to in vitro enzyme evidence.
-
Recombinant Human Growth Hormone: IGFBP2–THBS1 Evidence
2026-10-04
A source-grounded overview of recombinant human growth hormone research, emphasizing a 2025 study of the IGFBP2–THBS1–IGF-1 axis in idiopathic short stature, the strength of its cellular and patient-plasma evidence, and the limits of translating these findings into clinical conclusions.
-
HyperScript™ RT SuperMix: Reading Cell-Fate Change
2026-10-03
HyperScript RT SuperMix for qPCR offers a useful lens for interpreting gene expression during cancer cell-state conversion. This article connects reverse transcription design with evidence from a 2026 PDAC adipogenic transdifferentiation study while clarifying what qPCR can—and cannot—establish.
-
Hoechst 33342 for Fibroblast Senescence Assays
2026-10-02
Explore how Hoechst 33342 nuclear stain strengthens live and fixed fibroblast senescence assays. This article explains how nuclear readouts complement mitochondrial quality measurements without being mistaken for direct evidence of mitophagy.
-
AO/PI Staining Solution for Better Cell Viability Data
2026-10-01
Discover how AO/PI Staining Solution converts membrane integrity into a practical live/dead cell readout for diabetic nephropathy research. This guide connects dual-fluorescence counting with the mechanistic findings of the phillygenin study while defining appropriate assay limits and controls.
-
Lactobacillus acidophilus, UDCA, and Ulcerative Colitis
2026-10-01
Deng et al. show that Lactobacillus acidophilus may alleviate ulcerative colitis through a microbiota-dependent increase in ursodeoxycholic acid, rather than through probiotic administration alone. Their in vivo, metabolomics, and cell-based experiments connect UDCA with enhanced Treg differentiation, reduced M1 macrophage polarization, and regulation of the RapGap/PI3K-AKT/NF-κB pathway.
-
DBcAMP Sodium Salt in Neurobiology
2026-09-30
Explore how Dibutyryl-cAMP, sodium salt can function as a controlled cAMP perturbation tool in neurobiology, from PKA assays to tau-focused models. This evidence-aware guide connects DBcAMP sodium salt with model selection, assay controls, and the Alzheimer’s disease findings of a 2024 brain-slice study.
-
DNase I (GMP-grade) in RNA-CRISPR Workflows
2026-09-30
DNase I (GMP-grade) can improve the interpretability of RNA-targeting CRISPR experiments by controlling DNA carryover during preparation and quality assessment. This article connects nuclease hygiene with the cytosolic crRNA design principles reported for Cas13 systems.